Filing Details
- Accession Number:
- 0001104659-22-065250
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-26 16:05:35
- Reporting Period:
- 2022-05-25
- Accepted Time:
- 2022-05-26 16:05:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1811764 | Point Biopharma Global Inc. | PNT | Pharmaceutical Preparations (2834) | 850800493 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1868209 | E. Neil Fleshner | 4850 West 78Th Street Indianapolis IN 46268 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-25 | 564,204 | $7.51 | 3,023,045 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 233,171 | Indirect | 1510789 Ontario Inc. |
| Common Stock | 358 | Indirect | Trust Controlled by Wife |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.75, inclusive. The reporting person undertakes to provide to POINT Biopharma Global Inc., any security holder of POINT Biopharma Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- A corporation controlled by Reporting Person.
- A trust, whose trustee is the Reporting Person's spouse.
Billionaire Hedge Funds
